Sarcosine

DB12519InvestigationalSmall molecule

Sarcosine has been investigated for the treatment of Schizophrenia.

Chemical structure of Sarcosine
Mechanism
Curator reviewed
Formula / weight
C3H7NO2 · 89.0932 g/mol (avg)

Resolves to

Compound
UNIIZ711V88R5FCAS107-97-1ChEMBLCHEMBL304383ChEBI57433PubChem1088KEGGC00213
Clinical / RWD
RxNorm1362906
Structure
InChIKeyFSYKKLYZXJSNPZ-UHFFFAOYSA-NSMILESCNCC(O)=O
Targets
P48067SLC6A9
Transporters
Q7Z2H8SLC36A1

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
13+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Sarcosine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In